Showing results (121-130 of 2,547) with videos related to
Sort By:
Pageof 255
American Journal of Therapeutics|September 17, 2010
Opioid-induced hyperalgesia and toleranceMary Hanna BekhitAmerican Journal of Therapeutics|December 15, 2010
Are patients aware of angiotensin-converting enzyme inhibitor-associated adverse effects?Anastasia Khoubaeva, Kate Murray, Patricia M Mitchell, et al.American Journal of Therapeutics|May 13, 2010
Hand-foot hyperpigmentation skin lesions associated with combination gemcitabine-carboplatin (GemCarbo) therapyRoman L Kleynberg, Aijaz A Sofi, Rekha T ChaudharyAmerican Journal of Therapeutics|May 12, 2010
Vomiting from multivitamins: a potential drug interactionFrank Greenway, Ken Fujioka, Ying YuAmerican Journal of Therapeutics|May 12, 2010
Zolpidem misuse with other medications or alcohol frequently results in intensive care unit admissionAmy Zosel, E Charles Osterberg, Mark B MycykAmerican Journal of Therapeutics|June 3, 2009
N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patientsMark A Babizhayev, Philip Micans, Andrea Guiotto, et al.American Journal of Therapeutics|June 19, 2009
Cardiovascular risk awareness, treatment, and control in urban Latin AmericaHonorio Silva, Rafael Hernandez-Hernandez, Raul Vinueza, et al.American Journal of Therapeutics|June 19, 2009
Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis casesParvaneh Baghaei, Payam Tabarsi, Ehsan Chitsaz, et al.American Journal of Therapeutics|May 7, 2009
A randomized, placebo-controlled trial of an amino acid preparation on timing and quality of sleepWilliam Shell, Debbie Bullias, Elizabeth Charuvastra, et al.American Journal of Therapeutics|May 7, 2009
Allometric modeling of ciclesonide, a nonhalogenated glucocorticoid, and its active metabolite, desisobutyrylciclesonide, using animal-derived pharmacokinetic parametersNuggehally R Srinivas, Preeti Ahlawat, Jafar Bhasha ShaikPageof 255